Answers are grounded in this paper and cite their sources.
In recent years, utilizing bacteriophages to combat multidrug-resistant bacteria such as Pseudomonas aeruginosa has gained significant global attention. This research describes the isolation and detailed characterization of two lytic Pseudomonas phages, Isf1 and Isf2 , recovered from wastewater samples. Transmission electron microscopy analysis showed Isf1 belongs to the Siphoviridae family, whereas Isf2 represents a Podoviridae member. Both phages displayed efficient adsorption kinetics, achieving roughly 50% adsorption within 8–10 min, and burst sizes of ∼100 PFU and 70 PFU per infected cell, respectively. Isf1 maintained viability across 4–50°C and Isf2 across 4–40°C and pH conditions (6.0–9.0). Genomic sequencing revealed dsDNA genomes measuring 94,579 bp (55.19% GC) and 44,746 bp (52.50% GC) for Isf1 and Isf2 , respectively. Comparative studies demonstrated separate evolutionary pathways and different taxonomic classifications. BLASTn analysis indicated Isf1 possesses 98.45% identity with Pseudomonas phage SM1, whereas Isf2 displays 96.44% identity with phage DL54. No virulence or antimicrobial resistance genes were identified, indicating their suitability for therapeutic purposes.
No takes yet. Share an insight, caveat, or question.
Haghighatfard et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: